vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and INDEPENDENCE REALTY TRUST, INC. (IRT). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $165.3M, roughly 1.2× INDEPENDENCE REALTY TRUST, INC.). On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 2.5%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 2.2%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

COLL vs IRT — Head-to-Head

Bigger by revenue
COLL
COLL
1.2× larger
COLL
$205.4M
$165.3M
IRT
Growing faster (revenue YoY)
COLL
COLL
+10.4% gap
COLL
12.9%
2.5%
IRT
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
2.2%
IRT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
IRT
IRT
Revenue
$205.4M
$165.3M
Net Profit
$17.0M
Gross Margin
62.5%
Operating Margin
29.6%
Net Margin
8.3%
Revenue YoY
12.9%
2.5%
Net Profit YoY
35.3%
EPS (diluted)
$0.48
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
IRT
IRT
Q1 26
$165.3M
Q4 25
$205.4M
$167.1M
Q3 25
$209.4M
$167.1M
Q2 25
$188.0M
$162.2M
Q1 25
$177.8M
$161.2M
Q4 24
$181.9M
$161.0M
Q3 24
$159.3M
$160.1M
Q2 24
$145.3M
$158.4M
Net Profit
COLL
COLL
IRT
IRT
Q1 26
Q4 25
$17.0M
$33.3M
Q3 25
$31.5M
$6.9M
Q2 25
$12.0M
$8.0M
Q1 25
$2.4M
$8.4M
Q4 24
$12.5M
$-1.0M
Q3 24
$9.3M
$12.4M
Q2 24
$19.6M
$10.4M
Gross Margin
COLL
COLL
IRT
IRT
Q1 26
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Operating Margin
COLL
COLL
IRT
IRT
Q1 26
Q4 25
29.6%
Q3 25
29.7%
Q2 25
18.7%
Q1 25
12.2%
Q4 24
20.9%
Q3 24
21.9%
Q2 24
32.7%
Net Margin
COLL
COLL
IRT
IRT
Q1 26
Q4 25
8.3%
19.9%
Q3 25
15.0%
4.1%
Q2 25
6.4%
5.0%
Q1 25
1.4%
5.2%
Q4 24
6.9%
-0.6%
Q3 24
5.9%
7.7%
Q2 24
13.5%
6.5%
EPS (diluted)
COLL
COLL
IRT
IRT
Q1 26
$0.00
Q4 25
$0.48
$0.14
Q3 25
$0.84
$0.03
Q2 25
$0.34
$0.03
Q1 25
$0.07
$0.04
Q4 24
$0.36
$-0.01
Q3 24
$0.27
$0.05
Q2 24
$0.52
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
IRT
IRT
Cash + ST InvestmentsLiquidity on hand
$386.7M
$23.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$3.4B
Total Assets
$1.7B
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
IRT
IRT
Q1 26
$23.3M
Q4 25
$386.7M
$23.6M
Q3 25
$285.9M
$23.3M
Q2 25
$222.2M
$19.5M
Q1 25
$197.8M
$29.1M
Q4 24
$162.8M
$21.2M
Q3 24
$120.0M
$17.6M
Q2 24
$271.6M
$21.0M
Total Debt
COLL
COLL
IRT
IRT
Q1 26
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.2B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Stockholders' Equity
COLL
COLL
IRT
IRT
Q1 26
$3.4B
Q4 25
$301.7M
$3.5B
Q3 25
$274.8M
$3.5B
Q2 25
$232.2M
$3.4B
Q1 25
$234.4M
$3.5B
Q4 24
$228.8M
$3.4B
Q3 24
$234.3M
$3.4B
Q2 24
$216.6M
$3.4B
Total Assets
COLL
COLL
IRT
IRT
Q1 26
$6.1B
Q4 25
$1.7B
$6.0B
Q3 25
$1.6B
$6.1B
Q2 25
$1.6B
$6.0B
Q1 25
$1.6B
$6.0B
Q4 24
$1.7B
$6.1B
Q3 24
$1.6B
$5.9B
Q2 24
$1.1B
$5.9B
Debt / Equity
COLL
COLL
IRT
IRT
Q1 26
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.66×
Q1 25
0.65×
Q4 24
0.68×
Q3 24
0.68×
Q2 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
IRT
IRT
Operating Cash FlowLast quarter
$123.0M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
IRT
IRT
Q1 26
Q4 25
$123.0M
$282.1M
Q3 25
$78.4M
$79.3M
Q2 25
$72.4M
$82.2M
Q1 25
$55.4M
$60.4M
Q4 24
$84.6M
$259.8M
Q3 24
$-9.0M
$69.2M
Q2 24
$67.4M
$83.0M
Free Cash Flow
COLL
COLL
IRT
IRT
Q1 26
Q4 25
$122.4M
Q3 25
$78.3M
Q2 25
$72.4M
Q1 25
$54.6M
Q4 24
$84.1M
Q3 24
$-9.2M
Q2 24
$67.1M
FCF Margin
COLL
COLL
IRT
IRT
Q1 26
Q4 25
59.6%
Q3 25
37.4%
Q2 25
38.5%
Q1 25
30.7%
Q4 24
46.2%
Q3 24
-5.8%
Q2 24
46.2%
Capex Intensity
COLL
COLL
IRT
IRT
Q1 26
Q4 25
0.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.2%
Q2 24
0.2%
Cash Conversion
COLL
COLL
IRT
IRT
Q1 26
Q4 25
7.25×
8.48×
Q3 25
2.49×
11.51×
Q2 25
6.05×
10.22×
Q1 25
22.92×
7.23×
Q4 24
6.75×
Q3 24
-0.96×
5.60×
Q2 24
3.44×
8.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

IRT
IRT

Rental and other property revenue$165.2M100%
Other revenue$109.0K0%

Related Comparisons